MISONIDAZOLE (MISO) has now reached
Phase III prospective randomized clinical trials as an adjunct to radiotherapy. It was introduced in the first instance as a radiosensitizer of hypoxic cells (Asquith, et al., 1974) but laboratory investigations soon showed that MISO is also specifically cytotoxic for hypoxic cells after prolonged exposure (Sutherland, 1974; Hall & RoizinTowle, 1975) and that the sensitizing effectiveness of a given concentration of the drug is enhanced by prolonged incubation of the hypoxic cells with the drug before irradiation Wong et al., 1978) . While the mechanism for this preincubation effect is not entirely clear, there is good evidence that it is due in part to the depletion of non-protein sulphhydryl compounds in the cell by the prolonged exposure to MISO (Biaglow et al., 1981; Hall et al., 1982) .
When MISO is used in clinical radiotherapy, it is common practice to irradiate 4 h after oral administration, when drug concentration has reached a maximum in the tumour. If irradiation were further delayed, 2 processes would operate simultaneously. First, the drug concentration would decrease exponentially due to drug excretion. Second, the effective radiosensitizing effectiveness of the remaining drug would increase due to the preincubation or prolonged storage. Whether the resultant effect of combining these two processes would be an overall increase or decrease of radiosensitizing effectiveness with increased time between drug adminAccepted 2 April 1982 istration and irradiation must depend upon the half-life of the drug, the dose and time relationships for the pre-incubation effect, and the shape of the curve relating enhancement ratio (ER) to concentration of MISO. It is not possible to predict the outcome from previously available data, and the present paper describes experiments in which cells, cultured in vitro, were used to simulate the in vivo situation and to investigate the effect of prolonged incubation before irradiation for a range of simulated drug half-lives.
Chinese hamster (V79) cells were used for these experiments, grown in FIO culture medium supplemented with 10% fetal bovine serum, penicillin and streptomycin. Cells were irradiated in suspension in glass vessels specially fabricated based on the design of Chapman et al. (1977) . Cells were kept in suspension at a concentration of 2 x 106/ml by means of a magnetic stirrer, maintained at 37 5°C by immersion of the glass vessel in a water bath, and made hypoxic by passing highpurity N2 ( < 10 pt/106 of 02) plus 5% CO2 over the surface of the stirred cell suspension for a period of 1 h. Meanwhile the MISO, dissolved in complete growth medium, was degassed in a separate glass vessel and added to the cells to achieve a final concentration of 1 mm when both cells and drug were hypoxic. Parallel cultures were gassed with air plus CO2 and handled in the same way. One vessel containing cells was irradiated 5 min after the addition of the MISO in order to assess 
